PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...
4don MSN
With the 24% cuts and PEPFAR discontinued, we estimated there could be 4.43 million to 10.75 million additional HIV ...
On the heels of federal funding cuts for supporting HIV/AIDS studies and prevention services, LivWell Community Health ...
If we commit the necessary resources now, we can write the final chapter in the history of HIV, writes the director of AIDS ...
If all is good, then why do we need new options? Yes, HIV treatment – daily oral regimen – is lifesaving and good – access to ...
There’s no cure yet for HIV or stage 3 HIV, also known as AIDS. However ... medications as prescribed, the drugs could stop working for them, and the virus could start multiplying.
We have been carrying out targeted screenings among high-risk groups, including sex workers and injecting drug users (IDUs), ...
The long-acting injectable drug for PrEP, cabotegravir, sold under the brand name Apretude, was approved by Health Canada in 2024 to reduce the risk of sexually acquired HIV. The antiretroviral ...
He says Quebec's coverage of injectable PrEP under its public prescription drug insurance plan is an important step in the fight against AIDS. (Alison Northcott/CBC) Quebec's coverage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback